CFTR modulator therapy partially resolves inflammation in CF lung disease

被引：0
|
作者：
Maher, Rosemary [1 ]
Barry, Peter [2 ]
Emmott, Edward [1 ]
Jones, Andrew [2 ]
Lin, Lijing [3 ]
Mcnamara, Paul [4 ]
Smith, Jaclyn [5 ]
Lord, Robert [2 ]
机构：
[1] Univ Liverpool, Ctr Proteome Res, Liverpool, Merseyside, England
[2] Manchester Univ NHS Fdn Trust, Manchester Adult CF Ctr, Manchester, Lancs, England
[3] Univ Manchester, Fac Biol Med & Hlth, Manchester, Lancs, England
[4] Univ Liverpool, Dept Child Hlth, Inst Pk, Liverpool, Merseyside, England
[5] Manchester Univ NHS Fdn Trust, Dept Resp Med, Manchester, Lancs, England
来源：
EUROPEAN RESPIRATORY JOURNAL | 2023年 / 62卷
关键词：
D O I：
10.1183/13993003.congress-2023.PA2964
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [31] MICROBIOME, MUCUS AND INFLAMMATION IN EARLY CF LUNG DISEASE
    Muhlebach, M. S.
    Zorn, B.
    Esther, C. R.
    Kesimer, M.
    Hill, D. B.
    Ehre, C.
    Stick, S. M.
    Ranganathan, S.
    Boucher, R. C.
    Wolfgang, M.
    PEDIATRIC PULMONOLOGY, 2016, 51 : 326 - 326
  • [32] Substrate Utilisation During Exercise in Children with CF and Healthy Controls- The Impact of CFTR Modulator Therapy
    Selvadurai, H.
    Kennedy, B.
    Bailey, B.
    John, M.
    Kench, A.
    Selvadurai, Y.
    Middleton, A.
    Weldon, E.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [33] Personalized medicine in CF: from modulator development to therapy for cystic fibrosis patients with rare CFTR mutations
    Harutyunyan, Misak
    Huang, Yunjie
    Mun, Kyu-Shik
    Yang, Fanmuyi
    Arora, Kavisha
    Naren, Anjaparavanda P.
    AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2018, 314 (04) : 1529 - 1543
  • [34] Preservation of β-Cell Function in Pancreatic Insufficient Cystic Fibrosis (CF) with Highly Effective CFTR Modulator Therapy
    Flatt, Anneliese
    Sheikh, Saba
    Peleckis, Amy J.
    Gallagher, Kathryn
    Alvarado, Paola
    Hadjiliadis, Denis
    Stefanovski, Darko
    Gallop, Robert J.
    Rubenstein, Ronald C.
    Rickels, Michael R.
    Kelly, Andrea
    DIABETES, 2022, 71
  • [35] CFTR PARTNERS AS POTENTIAL MODIFIERS OF CF AIRWAY INFLAMMATION
    Fanen, Pascale
    Aissat, Abdel
    de Becdelievre, Alix
    Rocca, Jeremy
    Haddad, Laura
    Wohlhuter-Haddad, Adeline
    Drevillon, Loic
    Hinzpeter, Alexandre
    Tarze, Agathe
    PEDIATRIC PULMONOLOGY, 2014, 49 : 151 - 152
  • [36] IMPACT OF CFTR MODULATOR THERAPY (LEXACAFTOR/TEZACAFTOR/IVACAFTOR) ON PSEUDOMONAL COLONIZATION AND INFLAMMATION IN CYSTIC FIBROSIS
    Sheikh, Shahid I.
    Britt, Rodney D.
    Ryan-Wenger, Nancy A.
    Khan, Aiman Q.
    Gushue, Courtney A.
    McCoy, Karen S.
    Kopp, Benjamin
    CHEST, 2022, 162 (04) : 1519A - 1520A
  • [37] ABSENCE OF INFLAMMATION PRIOR TO THE ONSET OF LUNG DISEASE IN CFTR-/- PIGS
    Ramachandran, S.
    Wohlford-Lenane, C.
    Meyerholz, D. K.
    Stoltz, D. A.
    Pezzulo, A. A.
    Zabner, J.
    Welsh, M. J.
    McCray, P. B.
    PEDIATRIC PULMONOLOGY, 2010, : 291 - 291
  • [38] Fertility, Pregnancy and Lactation Considerations for Women with CF in the CFTR Modulator Era
    Jain, Raksha
    Taylor-Cousar, Jennifer L.
    JOURNAL OF PERSONALIZED MEDICINE, 2021, 11 (05):
  • [39] THE ROLE OF INFLAMMATION IN CF LUNG DISEASE: ASSESSMENT, CONSEQUENCES AND TREATMENTS
    Cohen-Cymberknoh, Malena
    PEDIATRIC PULMONOLOGY, 2014, 49 : 178 - 180
  • [40] Triple CFTR Modulator Therapy for Cystic Fibrosis
    Holguin, Fernando
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (17): : 1671 - +
12345